摘要
人们生活水平的提高和生活方式的改变,高血脂人群也逐渐增多。吉非罗齐是临床常用的降脂药物,本文将系统查阅并收集国内外的相关文献,从药理及临床两方面对降脂药吉非罗齐的研究现状进行综述,为吉非罗齐的进一步研究提供了文献基础。
With the improvement of people′s living standard and the change of life style,the number of people with high blood lipid is also increasing.Gemfibrozil is a commonly used lipid-lowering drug in clinic.In this paper,we summarize the pharmacologic actions and clinical applications of Gemfibrozil by referring to the relevant literatures published at home and abroad.It provides a literature basis for the further study of Gemfibrozil.
作者
黄秋妹
肖春芬
石茗
王珍
倪明龙
HUANG Qiu-mei;XIAO Chun-fen;SHI Ming;WANG Zhen;NI Ming-long(Guangdong Food and Drug Vocational College,Guangzhou 510520,China)
出处
《海峡药学》
2020年第1期108-111,共4页
Strait Pharmaceutical Journal
基金
广东省医学科学技术研究基金项目(B2017062,A2019324)
广东食品药品职业学院自然科学研究项目(2016YZ029,2016YZ033)
关键词
吉非罗齐
药理作用
临床应用
研究进展
Gemfibrozil
Pharmacologic actions
Clinical applications
Research progress
